Author:
Begg Stephen,Vos Theo,Goss John,Mann Nicholas
Abstract
Objective: To introduce a large body of work that
explores the modelling of expenditure on health
services per person living with major causes of
disease or injury as a valid basis for conclusions
regarding future health expenditure in Australia.
Methods: Separate projections were calculated for
important health conditions (or groups of conditions)
by type of expenditure (hospital care, medical services,
pharmaceuticals, aged care homes and other
health services). Analyses accounted for expected
changes in the number of affected cases, the proportion
of cases treated, the volume of health services
per treated case and excess health price inflation.
Results: Total health expenditure in Australia is
expected to increase from 9.4% of GDP in 2002?03
to 10.8% of GDP in 2032?33. This represents a 15%
increase in the ?health :GDP? proportion over the
projection period, or an annual growth of 0.5%. Twothirds
of this growth is accounted for by expected
increases in population size and population ageing.
Conclusions: The lower annual growth in the
?health :GDP? proportion compared with other estimates
for Australia (range, 0.9% to 1.7%) was
attributed to different assumptions regarding nondemographic
growth factors, particularly volume per
case. Explicit modelling of these factors separately
for each condition ensured that assumptions
remained within plausible limits.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Future health expenditures and its determinants in Latin America and the Caribbean: a multi-country projection study;The Lancet Regional Health - Americas;2024-05
2. Health Expenditure Data, Analysis and Policy Relevance in Australia, 1967 to 2020;International Journal of Environmental Research and Public Health;2022-02-14
3. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;The Lancet;2018-11
4. Adjusting health spending for the presence of comorbidities: an application to United States national inpatient data;Health Economics Review;2017-08-29
5. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015;The Lancet;2016-10